Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneScreen is a private healthcare services company focused on independent genetic counseling for patients and healthcare providers. The company provides pre- and post-test counseling, genetic risk assessment, test selection support, and results interpretation across reproductive health, hereditary cancer, cardiology, neurogenetics, and related areas. Its services are delivered through a technology-enabled, HIPAA-compliant platform that connects patients, providers, and board-certified genetic counselors, including a large remote counseling network across the U.S. and Canada. GeneScreen was founded by Jill Chisholm and later combined with Command Health in 2020 to form SynerGenomics, expanding its workflow, analytics, and AI-enabled support capabilities. The business appears to operate commercially as a provider-partnered genetic counseling organization rather than as a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneScreen Counseling.